According to the COSMIC catalog, SBS5 was found to be increased in bladder tumors with mutations in the DNA excision repair gene ERCC2, whereas signature SBS30 was found to be related to a deficiency in base excision repair due to inactivating mutations in NTHL1. The gene discussed is ERCC2; the disease is urinary bladder neoplasm.